Syed Kamran Mahmood
Overview
Explore the profile of Syed Kamran Mahmood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rehman J, Hussain F, Mahmood S, Un Nisa Q, Shahbaz N, Khan M
J Coll Physicians Surg Pak
. 2022 Dec;
32(12):1626-1628.
PMID: 36474390
Glanzmann's thrombasthenia (GT) is an autosomal recessive bleeding disorder characterised by mucocutaneous bleeding. At molecular level, defect in platelet receptor glycoprotein (GP) IIb/IIIa leads to defective platelet aggregation. Anti-fibrinolytic agents,...
2.
Iftikhar R, Chaudhry Q, Satti T, Mahmood S, Ghafoor T, Shamshad G, et al.
Clin Hematol Int
. 2021 Oct;
2(2):82-91.
PMID: 34595447
Allogeneic stem cell transplant for high-risk aplastic anemia (AA) yields inferior results using conventional cyclophosphamide (CY)-based conditioning. The use of fludarabine (Flu)-based regimens has resulted in improved outcomes in high-risk...
3.
Iftikhar R, Chaudhry Q, Mahmood S, Ghafoor T, Shahbaz N, Khan M, et al.
Bone Marrow Transplant
. 2021 Jun;
56(9):2309-2311.
PMID: 34172891
No abstract available.
4.
Iftikhar R, Chaudhry Q, Anwer F, Neupane K, Rafae A, Mahmood S, et al.
Blood Rev
. 2020 Nov;
47:100772.
PMID: 33187812
Treatment options for newly diagnosed aplastic anemia (AA) patient includes upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive therapy (IST). With recent advances in supportive care, conditioning regimens and...
5.
Khan M, Iftikhar R, Ghafoor T, Hussain F, Chaudhry Q, Mahmood S, et al.
Bone Marrow Transplant
. 2020 Nov;
56(4):863-872.
PMID: 33184452
Management of rare hematological disorders pose unique diagnostic and therapeutic challenges due to unusual occurrence and limited treatment options. We retrospectively identified 45 patients receiving matched related donor transplant for...
6.
Iftikhar R, Chaudhry Q, Mahmood S, Ghafoor T, Satti H, Shahbaz N, et al.
Biol Blood Marrow Transplant
. 2020 Jul;
26(12):2245-2251.
PMID: 32717437
Cyclosporine (CsA) combined with short-course methotrexate is considered standard-of-care graft-versus-host disease (GVHD) prophylaxis for patients with severe aplastic anemia (AA) who undergo transplantation using cyclophosphamide (Cy) plus anti-thymocyte globulin (ATG)...
7.
Toor S, Satti T, Iftikhar R, Mahmood S, Shamshad G, Rehman J
J Coll Physicians Surg Pak
. 2020 Jun;
30(5):527-531.
PMID: 32580853
Objective: To compare the efficacy and side effect profile of different bortezomib-based triplet regimens for remission induction in patients with multiple myeloma (MM). Study Design: Observational study. Place And Duration...
8.
Ahmed P, Chaudhry Q, Satti T, Mahmood S, Ghafoor T, Shahbaz N, et al.
Hematology
. 2020 Jan;
25(1):48-54.
PMID: 31906834
Prevalence of aplastic anemia (AA) is high in the Asian population. This study was done to explore the etiology and association of AA with various socio-economic and environmental factors. Study...
9.
Chaudhry Q, Iftikhar R, Satti T, Mahmood S, Ghafoor T, Shamshad G, et al.
Biol Blood Marrow Transplant
. 2019 Aug;
25(12):2375-2382.
PMID: 31394274
Despite excellent transplant outcomes of aplastic anemia (AA) in developed countries, management in developing countries is challenging because of delay in the diagnosis, use of family donors for transfusions, and...
10.
Iftikhar R, Chaudhry Q, Satti T, Mahmood S, Ghafoor T
Clin Case Rep
. 2019 Jul;
7(7):1442-1444.
PMID: 31360508
Post-transplant lymphoproliferative disorders are rare but potentially life-threatening complication of HSCT. Although not frequently reported but PTLD can occur as a late post-transplant complication in HSCT recipients. A high index...